This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Industry Trends Largest Transactions Closed Target Buyer Value($mm) Please Share This Tweet Share Pin It Share RELATED RESOURCE PCE Names Valuation Practice Leader Read now RELATED RESOURCE Resource Title goes here Read now PCE Investment Bankers, Inc. You can depend on us to deliver maximum results.
Business photo created by rawpixel.com – www.freepik.com CHICAGO, IL – February 23, 2024 – A distinguished specialty plastics provider for medical devices out of Northern California, has initiated a sell-side engagement represented by Sun Acquisitions.
Navigating M&A valuations with precision is paramount for informed decision-making. Our guide equips you with step-by-step instructions on employing the Enterprise Value Calculator effectively, complete with insights into optimal practices for precision valuations. Let’s dive into the intricacies of this invaluable resource.
In a roll-up strategy, a private equity firm will attempt to consolidate a large number of smaller firms into a single, professionalized company with numerous benefits, including economies of scale and fixed cost leverage, valuation uplift (so-called “multiple arbitrage”), and acquisition expertise, among others.
continues their goal of acquiring and integrating leading medical aesthetics clinics, enabling medical professionals in their subsidiaries to achieve personal and professional goals while creating world-class customer experiences by networking support, collaboration, and community. About MedSpa Partners Inc.
These products are used for food packaging and processing, medical, printing, automotive, material handling systems and other applications. Sun also provided advisory services throughout the diligence period. We work with clients that are interested in the confidential sale , acquisition or valuation of privately held companies.
Specializing in precision metal services and medical manufacturing, Grace has earned a stellar reputation for delivering custom metal parts utilizing various cutting-edge processes. with advisory services throughout the diligence period. New owners Grace Manufacturing boasts a rich history, having been founded in 1966.
(“Rendia”), a provider of subscription-based point-of-care engagement software and content for eye care practitioners, in its sale to PatientPoint ® (“PatientPoint”), provider of an industry-leading, tech-enabled point-of-care network that engages healthcare providers and patients across 20 medical specialties.
Return Logistics International was established in 1996, and currently provides manufacturer returns processing, as well as product and waste destruction and disposal for manufacturers, wholesalers, retail and institutional pharmacies, medical practitioners and dispensers, animal hospitals, animal clinics, and veterinarians.
We also note that while institutional stockholders and proxy advisory firms remain opposed to gross-ups as a matter of policy, the inclusion of deal specific gross-ups has not appeared to have any practical impact on the outcome of transactions to date. billion acquisition of Alere. million to $84.4 Use of Earn-Outs in Life Sciences Deals.
Amid depressed valuations, biotechnology companies also saw an increasing number of demands from activist investors that in certain cases led to more deal activity. For example, the sale of Horizon Therapeutics to Amgen for approximately $28 billion was the third-largest all-cash transaction in the pharmaceutical sector in history.
In technology, as a startup keeps raising capital, it normally does so at gradually higher valuations as its customers, users, and revenue grow. But in biotech, companies valuations often remain close to their total capital raised until much later in the process (i.e., If you have an advanced medical or academic background (e.g.,
As a result, we are seeing important shifts in deal structure, and in many respects, larger differences in EBITDA calculations, valuation, and how transaction proceeds are paid than we did historically. Different post-transaction compensation formulas will create different valuations. Some buyers have become more conservative.
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content